Decatur, GA, United States of America

Venkata Subba Rao Mukkavilli

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Venkata Subba Rao Mukkavilli: Innovator in Cancer Treatment

Introduction

Venkata Subba Rao Mukkavilli is a notable inventor based in Decatur, GA (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 2 patents, his work focuses on innovative methods and compositions that aim to improve patient outcomes.

Latest Patents

Mukkavilli's latest patents include a groundbreaking method for treating cancer using ethanolamine-based lipid biosynthetic compounds. This method involves administering an effective amount of a pharmaceutical composition that includes monoethanolamine, its prodrug or hybrid molecule, or a pharmaceutically acceptable salt thereof, along with a suitable carrier. The composition can be formulated for various routes of administration, including oral, intravenous, intraperitoneal, subcutaneous, dermal, or intranasal.

Career Highlights

Throughout his career, Mukkavilli has worked with several prominent companies in the pharmaceutical industry. Notable among these are Metanoi Therapeutics, Inc. and Novazoi Theranostics. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Mukkavilli has collaborated with various professionals in his field, including his coworker Ritu Aneja. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Venkata Subba Rao Mukkavilli is a distinguished inventor whose work in cancer treatment showcases his innovative spirit and dedication to improving healthcare. His contributions through patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…